Acta Scientific Paediatrics

Perpesctive Volume 6 Issue 9

The Child with Autistic Spectrum Disorder — Current Perspective

Abdul Halim Abdul Jalil*

KPJ Ampang Puteri Specialist Hospital, Selangor, Malaysia

*Corresponding Author: Abdul Halim Abdul Jalil, Consultant Paediatrician, KPJ Ampang Puteri Specialist Hospital, Selangor, Malaysia.

Received: October 03, 2023; Published: October 16, 2023


One in 1000 children between the ages of 3 and 9 was found to have autism from an epidemiological study conducted in Malaysia in 1981 as part of a collaborative international pilot study [1]. Currently, autistic spectrum disorder (ASD] is one of the top five developmental impairments in children under the age of 5 in 195 nations and territories [2]. The prevalence is undoubtedly considerably much higher now than it was in the past. The three core criteria of autistic spectrum disorder (ASD) are impairment in social interaction, impairment in communication and restrictive repetitive and stereotypic patterns of behavior, interests and activities. It is feasible to diagnose childhood autism as early as under 2 years of age with a suitable screening tool, such as functional developmental evaluation questionnaires, followed by a neurodevelopmental assessment by a pediatrican in suspected cases.


  1. Kassim MS and Halim AJ. “Survey for identification of severe childhood disability in Malaysia”. Proceedings of the 17'h International Congress of Pediatrics (1986).
  2. Theo Vos., et al. “Global, Regional, and National Incidence, Prevalence, and Years Lived with Disability for 310 Diseases and Injuries, 1990-201S: A Systematic Analysis for the Global Burden of Disease Study 2015”. The Lancet10053 (2016): 1545-1602.
  3. Ecker C., et al. “Neuroimaging in autism spectrum disorder: Brain structure and function across the lifespan”. The Lancet Neurology11 (2015): 1121-1134.
  4. Kristen R Choi., et al. “Patient Outcomes After Applied Behavior Analysis for Autism Spectrum Disorder”. Journal of Developmental and Behavioral Pediatrics 1 (2022): 9-16.
  5. Abdul Halim Abdul Jalil. “Hope for Untreatable medical Disorders. Live cell therapy explained”. Troubador Publishing Ltd. UK.(2017)
  6. DA Rossignol and RE Frye. “Mitochondrial dysfunction in autism spectrum disorder: A systematic review and meta-analysis”. Molecular Psychiatry 17 (2012): 290-314.
  7. Abdul Halim Abdul Jalil and Mohamed Lokman Md Isa. “Live cell therapy: Past, present and future”. Journal of Reproductive Biotechnology and Fertility 11 (2022).


Citation: Abdul Halim Abdul Jalil.,et al. “The Child with Autistic Spectrum Disorder — Current Perspective".Acta Scientific Paediatrics 6.9 (2023): 08-09.


Copyright: © 2023 Abdul Halim Abdul Jalil., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate33%
Acceptance to publication20-30 days
Impact Factor1.197

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 10, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US